GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer

NCT05575804 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Advanced/ Metastatic Her-2 Positive Breast Cancer

Interventions

DRUG: GQ1001+pyrotinib
DRUG: pyrotinib+capecitabine

Sponsor

Fudan University

Collaborators

[object Object]